Barclays PLC Ocugen, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Barclays PLC holds 453,415 shares of OCGN stock, worth $326,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
453,415
Previous 581,087
21.97%
Holding current value
$326,458
Previous $577,000
36.74%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OCGN
# of Institutions
126Shares Held
68.1MCall Options Held
634KPut Options Held
291K-
Black Rock Inc. New York, NY17.9MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.6MShares$12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$4.74 Million0.0% of portfolio
-
State Street Corp Boston, MA5.87MShares$4.22 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.77 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $156M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...